{"id":"NCT03781804","sponsor":"Optinose US Inc.","briefTitle":"Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps","officialTitle":"A 24-Week Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (BID) in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-27","primaryCompletion":"2022-01-19","completion":"2022-01-19","firstPosted":"2018-12-20","resultsPosted":"2023-09-18","lastUpdate":"2024-05-29"},"enrollment":332,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Rhinosinusitis"],"interventions":[{"type":"DRUG","name":"OPN-375","otherNames":[]}],"arms":[{"label":"OPN-375 186 μg BID","type":"ACTIVE_COMPARATOR"},{"label":"OPN-375 372 μg BID","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 μg twice daily (BID) of OPN-375 in subjects with chronic rhinosinusitis (CS) with or without nasal polyps.","primaryOutcome":{"measure":"Change From Baseline in Symptoms as Measured by a Composite Score for Each Symptom of Nasal Congestion, Facial Pain or Pressure Sensation, and Nasal Discharge (Anterior and/or Posterior) at the End of Week 4","timeFrame":"4 Weeks","effectByArm":[{"arm":"OPN-375 186 μg BID","deltaMin":-1.58,"sd":0.161},{"arm":"OPN-375 372 μg BID","deltaMin":-1.6,"sd":0.163},{"arm":"Placebo","deltaMin":-0.62,"sd":0.161}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":92,"countries":["United States","Bulgaria","Canada","Georgia","Poland","Russia","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":111},"commonTop":["Epistaxis","Nasopharyngitis","Acute sinusitis","Asthma","Cataract nuclear"]}}